openPR Logo
Press release

What's driving Patient-Controlled Analgesia Pumps Market Growth? Top Players: Becton Dickinson and Company, Baxter International, B.Braun Melsungen AG

06-10-2019 08:53 AM CET | Health & Medicine

Press release from: Future Market Insights

What's driving Patient-Controlled Analgesia Pumps Market

PCA or patient-controlled analgesia pumps is a way with which analgesic can be self-administered by the patient as and when needed. Patient-controlled analgesia pumps are not used to treat long term pains. PCA is used in various applications such as oncology or chemo therapy, pediatrics, gastroenterology, hematology and diabetes. There are several benefits of using PCA. It allows complete control on the pain treatment. It also assists in preventing the formation of blood clots and promotes healing at a faster rate. However, there are certain disadvantages, the main aspect being an occurrence of an over dost or an under dose that can take place in case of improper settings and programming of the device. Government initiatives to boost home medication, rising awareness about patient-controlled analgesia pumps, and affordable costs are few of the aspects contributing to the expansion of patient-controlled analgesia pumps market at a global level.

The global patient-controlled analgesia pumps market is projected to grow at a high CAGR during the period of forecast and is estimated to reflect a valuation of above US$ 500 Mn by the end of the year of forecast.

The research report has also profiled various leading players in the global patient-controlled analgesia pumps market. Companies like Becton Dickinson and Company, Baxter International, B.Braun Melsungen AG, Terumo Corporation, Ace Medical Co. Ltd., Micrel Medical Devices, Hospira (Pfizer Inc.), Fresenius Kabi Group and Smiths Group plc., have been profiled in this research report.

Download Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5710

Global Patient-Controlled Analgesia Pumps Market: Dynamics

The growth of the global patient-controlled analgesia pumps market is influenced by aspects such as various advantages of PCA system over conventional continuous infusion systems, increasing standardization for reducing costs in hospitals, development of quality indicators for patient-controlled analgesia pumps, modernization with a view to reduce errors, increasing adoption of PCA owing to increasing prevalence of cancer, pain and diabetes, rising forward integration and increasing demand for PCA in rental and homecare services. These factors have contributed to the growth of the global market. On the contrary, lack of skilled manpower and lack of standard usage guidelines and vast product recalls are hampering the growth of the global patient-controlled analgesia pumps market. Various trends have been observed, to name a few, rapid med-tech progress, shifting production base to emerging economies, user-friendly advanced equipment and fragmented market. Opportunities such as increasing production base for smart pumps with bigger drug libraries and expanding production base for PCA, ambulatory and other pumps have been boosting the growth of the global market.

Segmental Highlights

The global patient-controlled analgesia pumps market has been segmented by product type, by end user, by application and by region.

By product type, the PCA pumps segment is estimated to be the largest segment in terms of market value and likely to lead the global market. it is also projected to grow at a higher pace thus reflecting high potential for growth of global market in the coming years

By region, Asia Pacific excluding Japan (APEJ) region is projected to be the fastest growing with a high 9.6% CAGR during the forecast period. North America is the largest from a market share perspective

Download Methodology of Report @ https://www.futuremarketinsights.com/askus/rep-gb-5710

By end user, hospitals segment is the most lucrative. This segment dominated the global market in 2017 and is expected to lead the market by 2026 end with a valuation of more than US$ 200 Mn

By application, diabetes segment is the fastest growing segment with a high CAGR of 6.0% throughout the period of forecast

Patient Controlled Analgesia Pumps Market Reports - Table of Contents

1. Global Economic Outlook
2. Global Patient-Controlled Analgesia Pumps Market - Executive Summary
3. Global Patient-Controlled Analgesia Pumps Market Overview
4. Global Patient-Controlled Analgesia Pumps Market Analysis and Forecast 2012-2026
5. North America Patient-Controlled Analgesia Pumps Market Size and Forecast, 2012-2026
6. Latin America Patient-Controlled Analgesia Pumps Market Size and Forecast, 2012-2026
7. Europe Patient-Controlled Analgesia Pumps Market Size and Forecast, 2012-2026
8. Japan Patient-Controlled Analgesia Pumps Market Size and Forecast, 2012-2026
9. APEJ Patient-Controlled Analgesia Pumps Market Size and Forecast, 2012-2026
10. MEA Patient-Controlled Analgesia Pumps Market Size and Forecast, 2012-2026
11. Global Patient-Controlled Analgesia Pumps Market Company Share, Competition Landscape and Company Profiles
12. Research Methodology
13. Secondary and Primary Sources
14. Assumptions and Acronyms
15. Disclaimer

Buy Full Report Now @ https://www.futuremarketinsights.com/checkout/5710

Contact Us
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): + 44 (0) 20 7692 8790
Sales: sales@futuremarketinsights.com
Press Office: Press@futuremarketinsights.com
Website: https:www.futuremarketinsights.com

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving Patient-Controlled Analgesia Pumps Market Growth? Top Players: Becton Dickinson and Company, Baxter International, B.Braun Melsungen AG here

News-ID: 1769138 • Views:

More Releases from Future Market Insights

Freeze Dried Fruits Market to Double by 2035 Driven by Health Trends, Innovation, and Global Trade Expansion
Freeze Dried Fruits Market to Double by 2035 Driven by Health Trends, Innovation …
The global freeze-dried fruits market is projected to nearly double in size, rising from USD 9.97 billion in 2025 to USD 20.18 billion by 2035. This steady growth, supported by a compound annual growth rate (CAGR) of 7.3%, reflects the evolving consumer shift toward convenient, nutritious, and long-lasting food options. With busy lifestyles and heightened health awareness shaping food choices, freeze-dried fruits are gaining widespread popularity as they preserve flavor,
Sourdough Market Set to Flourish, Rising from USD 5.9 Billion in 2025 to USD 10.2 Billion by 2035
Sourdough Market Set to Flourish, Rising from USD 5.9 Billion in 2025 to USD 10. …
The global sourdough market is entering a transformative decade, projected to grow at a CAGR of 6.8% between 2025 and 2035. Market size is set to increase from USD 5.9 billion in 2025 to USD 10.2 billion by 2035, reflecting a powerful consumer shift toward naturally fermented, clean-label, and artisanal bakery products. Sourdough is no longer confined to traditional bread-it has evolved into a global phenomenon embraced for its flavor,
Probiotic Ingredients Market to Hit USD 12 Billion by 2035 Fueled by Gut Health and Functional Food Demand
Probiotic Ingredients Market to Hit USD 12 Billion by 2035 Fueled by Gut Health …
The global probiotic ingredients market is entering a dynamic growth phase, with its value expected to rise from USD 8 billion in 2025 to USD 12 billion by 2035. This steady trajectory, projected at a CAGR of 3.3%, reflects the increasing global emphasis on digestive health and overall wellness. Consumers are turning to probiotics as trusted, science-backed solutions incorporated into everyday diets, fueling demand across food, beverage, and supplement categories. Bacterial
Global Fortified Yeast Market Projected to Expand at 13.5% CAGR to USD 447.0 Million by 2034
Global Fortified Yeast Market Projected to Expand at 13.5% CAGR to USD 447.0 Mil …
The global fortified yeast market is on an impressive growth trajectory, with the sector estimated to be valued at USD 190.2 million in 2024 and projected to reach USD 447.0 million by 2034, expanding at a CAGR of 13.5% during the forecast period. This surge is driven by increasing consumer demand for nutrient-dense foods, advancements in biotechnology, and the expansion of fortified yeast applications across food, pharmaceuticals, and animal nutrition

All 5 Releases


More Releases for Patient

Patient Portal Market: Empowering Patient-Centric Healthcare
In recent years, the global Patient Portal Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Patient Portal Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including
Patient Portal Market: Empowering Patient-Centric Healthcare
In recent years, the global Patient Portal Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Patient Portal Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including
Future Growth: Patient Advocacy Solutions Market Sees Promising Growth in 2024 | …
The latest research study released by Worldwide Market Reports on "Patient Advocacy Solutions Market 2024" holds tons of experience in offering comprehensive and accurate analysis of global as well as regional markets. The analysts and researchers authoring the report have provided a deeper competitive analysis of the Patient Advocacy Solutions market along with exhaustive company profiling of leading market players. This research study of the Patient Advocacy Solutions Market involved
Factors Influencing Global Digital Patient Empowerment Services Market through 2 …
The worldwide "Digital Patient Empowerment Services Market" 2023 Research Report presents a professional and complete analysis of the Global Digital Patient Empowerment Services Market in the current situation. This report includes development plans and policies along with Digital Patient Empowerment Services manufacturing processes and price structures. the reports 2023 research report offers an analytical view of the industry by studying different factors like Digital Patient Empowerment Services Market growth, consumption
10-11-2022 | Health & Medicine
Fact.MR
Growing Demand For Patient Handling Equipment & Patient Positioning Devices To A …
As per Fact.MR, a market research and competitive intelligence provider, the global patient lateral transfer devices market is anticipated to top US$ 500 Mn by 2031, progressing at a CAGR of 7% over the forecast period of 2021 to 2031. Lateral transfer is a repositioning aid or equipment that reduces friction and makes it easier and safer to transfer patients laterally. Patient lateral transfer devices are designed to stay with the
Patient Perspectives - Patient Reported Outcomes Drive Drug Development, But Imp …
GBI Research, the leading business intelligence provider, has released its latest research, Patient Perspectives Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge. The report examines the role of patients in changing the research agenda and helping pharma companies to bring effective medicines that meet real unmet medical needs into the market place. It explores the use of patient reported outcomes in drug development, with a